Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
PaperCitations, authors & open-access status
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 585 citations, 2017 year and green oa status.
585
Citations
2017
Year
green
OA Status